Pfizer stock is trading in a range where recent returns have been weak over three years, yet the broader valuation checks ...

Get the live share price of Pfizer Inc (PFE), including intraday charts, historical performance, key financials, and market ...

Pfizer (PFE) is back in focus for investors as its latest reported figures offer a snapshot of how the US$143.7b ...

Pfizer (PFE) closed at $24.08 in the latest trading session, marking a -1.19% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.79%. At the same time, the Dow ...

Investors continued to be positive on the pharmaceutical giant following a deal reached with the government. Among other benefits, it will have a reprieve from potential tariffs on its industry. 10 ...

I last covered Pfizer Inc. stock (NYSE:PFE) on Feb 19. The article rated the stock as hold after examining its FQ4 earnings report (ER) and dividend declarations. Since then, a few new catalysts have ...

Promising clinical results in 2026 could set the stage for Pfizer's stock to rebound. However, the company's COVID-19 product and patent cliff challenges could prevent a big bounce this year. Even if ...

Pfizer offers a 6.3% yield, but its high dividend reflects weak growth prospects and looming patent cliffs. PFE’s dividend is currently covered by cash flow, but payout ratios are stretched, and ...

Track Pfizer share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss ...